80 Peer-reviewed Clinical Studies
Can the SteriPlas:
Kill all forms of bacteria? YES ✔
Kill bacteria protected within biofilm? YES ✔
Operate safely with no side effects? YES ✔
Treat infected wounds in as quick as 2 minutes? YES ✔
Ready to learn more? Visit our website: https://adtechealthcare.com/cold-plasma-wound-treatment/
Our 80 peer-reviewed clinical trials and publications illustrate why our SteriPlas remains the leader for Cold Plasma with anti-biofilm efficacy
#medicaldistributor #MEDICA2023 #ABHI #Plasma #investorswanted #investor
Visit us at booth J60.3, Medica 2023
Next week we’ll be exhibiting at the Medica Trade Fair 2023 exhibition with the ABHI and UK Healthcare Pavilion. You can find us at booth J60.3 in Hall 16. Be sure to stop by to see our SteriPlas Premium Cold Plasma medical device live in action and ready to demonstrate its strong clinical efficacy for wounds, surgical site infections and medical dermatology conditions.
Adtec Healthcare is also eager to meet with new medical distributors to continue to expand the reach of our Cold Plasma globally. If you are a distributor and willing to learn about the strong cost saving benefits and accelerated healing of chronic wounds with biofilm please be sure to pay us a visit.
Medica Trade Fair 2023
We are delighted to be joining The Association of British HealthTech Industries (ABHI) and UK Healthcare Pavilion at the Medica Trade Fair next week, showcasing the strengths of UK HealthTech alongside 40 of the UK’s leading industry players. Come visit us at booth J60.3, Hall 16 and discover the best of the UK.
TFDA Approves SteriPlas in Taiwan
It is with great pleasure that we announce the SteriPlas Cold Plasma medical device is now an approved product in Taiwan, making it the first Cold Plasma medical device to be issued in the country. Adtec Healthcare Limited owes its thanks and praises to our exclusive distributor in Taiwan, SG Biomedical, whom without their skills in Regulatory and with the TFDA, none of this would have been possible.
The SteriPlas is already renowned in Taiwan for its strong clinical efficacy using premium and dense Cold Plasma and is set for distribution across the leading hospitals dealing with wound care. This is set to start within the coming months. If you are a health care professional in Taiwan that manages chronic wounds, we humbly request that you contact SG Biomedical who can guide you on the strong antibacterial benefits of the SteriPlas for diabetic foot ulcers, LVAD infections, sternal wounds and many more.
http://www.sghlds.com/index.php/tw/
SteriPlas Cold Plasma to be presented at EACTS 2023
We look forward to Mr Thomas Schlöglhofer’s presentation at the upcoming European Association for Cardio-Thoracic Surgery (EACTS) conference in Vienna on Fri 6th Oct. Thomas will present, “Cold Atmospheric Plasma Therapy as an Effective Treatment of Left Ventricular Assist Device Driveline Infections” which will feature the advantages of our SteriPlas Cold Plasma medical device for deep LVAD infections treated at the Department of Cardiac Surgery, Medical University of Vienna.
Adtec presents at the LSI today
It was a pleasure to present at the LSI - Life Science Intelligence in Barcelona today. The successes of Adtec Healthcare Ltd and our Premium Cold Plasma medical device, the SteriPlas, were presented to the audience with much interest.
If you would like to know more about our strong clinical efficacy and antibiofilm properties for chronic wounds and infections, send us an email at info@adtecplasma.com
Life Science Intelligence Conference in Barcelona
Adtec Healthcare Ltd will be presenting at the Life Science Intelligence (LSI) Barcelona from 18-22 September 2023. Our Managing Director, Mary, will be showcasing the successes Adtec Healthcare and the SteriPlas have brought to clinical practices dealing with non-healing chronic wounds burdened with biofilm. Mary’s presentation will be held at 10:35 - 10:44 on September 21st and we encourage you to attend and ask your questions to better learn why we remain the leader of high density Cold Plasma medicine.
Advanced Wound Care Summit 2023
We hope you got to see our presentation at the Advanced Wound Care Summit yesterday. We thoroughly enjoyed explaining the strong benefits of our SteriPlas Cold Plasma for biofilm destruction. If you would like to learn more about our medical device and clinical evidence, send us an email info@adtecplasma.com
Size Does Matter!
Size does matter!
Yes, we do manufacture smaller handheld Cold Plasma devices that have antibacterial efficacy but we do not sell these in the medical field. A quick 2 minute treatment time is respective of being focused on the size of the plasma area created. Small and handheld plasma jet devices feature a 1mm2 treatment area which means antibacterial efficacy is achieved in a very small area for every 2 minutes applied. If the wound is 10cm2, we will leave you to do the maths on how long it will take to treat! This is why we do not sell handheld plasma jet pens as medical devices as they are limited to small and superficial wounds.
The SteriPlas creates a gigantic 12cm2 treatment area which is only possible through the size of the medical device which incorporates a series of crucial components such as the generator and control unit. This means the SteriPlas can cover large wounds and finish treatment in as quick as a single two minute session. Whilst the SteriPlas can treat acute and superficial wounds, it is designed to target deep and complicated wounds with #biofilm.
Deep sternal wounds is a classic example as documented in our clinical evidence.
The Leader of Cold Plasma
There is expanding interest of our medical device for the treatment of chronic diabetic foot ulcers, deep sternal wounds and LVAD infections. We wish to remind you that if you are a Health Care Professional seeking to learn more about our medical device then please do get in contact with us. A member of our team will be able to show the full benefits and safety of using our medical device to treat these complicated conditions, with no side effects.
As Adtec Healthcare remains the leader of cold plasma medicine, we are lucky to be able to boast a wide clinical bibliography collection that really makes us stand out amongst the rest. We were the first company worldwide to do clinical trials of cold plasma on chronic wounds. Our clinical trials data has paved way in today’s medicine to show cold plasma as the go-to alternative for infection management.
If you are interested to bring the benefits of cold plasma to your patients, please email us at info@adtecplasma.com